...
首页> 外文期刊>World Journal of Gastroenterology >HLA and Polygonum multiflorum -induced liver injury in the Han Chinese population
【24h】

HLA and Polygonum multiflorum -induced liver injury in the Han Chinese population

机译:HLA和Polygonum Multiflorum-诱导汉族人口肝损伤

获取原文

摘要

BACKGROUND Polygonum multiflorum is one of the leading causes of herb-induced liver injury in China. HLA-B*35:01 is reported to be a potential biomarker of Polygonum multiflorum -induced liver injury (PM-DILI). However, little is known about the relationship between single-nucleotide polymorphisms (SNPs) and PM-DILI. AIM To identify SNPs that indicate susceptibility to PM-DILI. METHODS We conducted a systematic study enrolling 382 participants from four independent hospitals, including 73 PM-DILI patients, 118 patients with other drug-induced liver injury (other-DILI) and 191 healthy controls. Whole-exome sequencing was performed for 8 PM-DILI patients and 8 healthy controls who were randomly selected from the above subjects. Nineteen SNPs that showed high frequencies in the 8 PM-DILI patients were selected as candidate SNPs and then screened in 65 PM-DILI patients, 118 other-DILI patients and 183 healthy controls using the MassARRAY system. HLA-B high-resolution genotyping was performed for the 73 PM-DILI and 118 other-DILI patients. The Han-MHC database was selected as a population control for HLA-B analysis. P 6.25 × 10sup-3/sup after Bonferroni correction was considered significant. RESULTS The frequencies of rs111686806 in the HLA-A gene, rs1055348 in the HLA-B gene, and rs202047044 in the HLA-DRB1 gene were significantly higher in the PM-DILI group than in the control group [27.2% vs 11.6%, P = 1.72 × 10sup-5/sup, odds ratio (OR) = 3.96, 95% confidence interval (CI): 2.21-7.14; 42.5% vs 8.6%, P = 1.72 × 10sup-19/sup, OR = 13.62, 95%CI: 7.16-25.9; 22.9% vs 8.1%, P = 4.64 × 10sup-6/sup, OR = 4.1, 95%CI: 2.25-7.47]. Only rs1055348 showed a significantly higher frequency in the PM-DILI group than in the other-DILI group (42.5% vs 13.6%, P = 1.84 × 10sup-10/sup, OR = 10.06, 95%CI: 5.06-20.0), which suggested that it is a specific risk factor for PM-DILI. rs1055348 may become a tag for HLA-B*35:01 with 100% sensitivity and 97.7% specificity in the PM-DILI group and 100% sensitivity and 98.1% specificity in the other-DILI group. Furthermore, HLA-B*35:01 was confirmed to be associated with PM-DILI with a frequency of 41.1% in the PM-DILI group compared with 11.9% ( P = 4.30 × 10sup-11/sup, OR = 11.11, 95%CI: 5.57-22.19) in the other-DILI group and 2.7% ( P = 6.22 × 10sup-166/sup, OR = 62.62, 95%CI: 35.91-109.20) in the Han-MHC database. CONCLUSION rs111686806, rs1055348, and rs202047044 are associated with PM-DILI, of which, rs1055348 is specific to PM-DILI. As a tag for HLA-B*35:01 , rs1055348 may become an alternative predictive biomarker of PM-DILI.
机译:背景技术Polygonum Multiflorum是中国草药诱导的肝损伤的主要原因之一。据报道,HLA-B * 35:01是多谷物致肝损伤(PM-DIRI)的潜在生物标志物。然而,关于单核苷酸多态性(SNP)和PM-DIRI之间的关系很少。旨在识别表明对PM-DILI易感性的SNP。方法采用来自四家独立医院的382名参与者进行了系统研究,其中包括73例PM-DIRI患者,118名其他药物诱导的肝损伤(其他 - 帝力)和191例健康对照。对8例PM-DILI患者和8例健康对照进行全面测序,从上述受试者中随机选择。在候选SNP中出现了8例PM-DIRI患者的高频,然后在65例PM-DIRI患者中筛选,118名其他帝力患者和183名使用Massarray系统的健康对照。 HLA-B高分辨率基因分型对73例PM-DIRI和118名其他帝力患者进行。选择HAN-MHC数据库作为HLA-B分析的人口控制。 Bonferroni校正被认为是显着的P <6.25×10 -3 。结果PM-DIRI组在HLA-B基因中HLA-A基因,HLA-B基因的RS1055348中的RS111686806和HLA-DRB1基因的RS2047044的频率显着高于对照组[27.2%vs11.6%,p = 1.72×10 -5 ,odds比率(或)= 3.96,95%置信区间(CI):2.21-7.14; 42.5%vs 8.6%,p = 1.72×10 -19 ,或= 13.62,95%ci:7.16-25.9; 22.9%vs 8.1%,p = 4.64×10 -6 ,或= 4.1,95%ci:2.25-7.47]。仅RS1055348在PM-DILI组中显示出明显较高的频率,而不是在其他-ILI组中(42.5%Vs13.6%,P = 1.84×10 -10 ,或= 10.06,95%CI: 5.06-20.0),这表明它是PM-DILI的具体危险因素。 RS1055348可以成为HLA-B * 35:01的标签,PM-DIRI组的100%敏感性和97.7%的特异性,在其他帝力组中的100%敏感性和98.1%的特异性。此外,确认HLA-B * 35:01与PM-DIRI组中的频率为41.1%,与11.9%(P = 4.30×10 -11 ,或= 11.11,95%CI:5.57-22.19)在其他 - DiLi组和2.7%(P = 6.22×10 -166 ,或= 62.62,95%CI:35.91-109.20) Han-MHC数据库。结论RS111686806,RS111686806,RS1055348和RS202047044与PM-DILI相关联,其中RS1055348特异于PM-DILI。作为HLA-B * 35:01的标签,RS1055348可以成为PM-DiRi的替代预测生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号